Brucella melitensis Rev-1 vaccine as a cause of human brucellosis

Brucellosis is a bacterial infection caused by members of the genus brucella and remains one of the world's major zoonotic diseases. Discover the latest research on Brucellosis here.

Brucellosis (ASM)

Brucellosis is a bacterial infection caused by members of the genus brucella and remains one of the world's major zoonotic diseases. Discover the latest research on Brucellosis here.

Brucella melitensis Rev-1 vaccine as a cause of human brucellosis

Abstract

References

Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study

An outbreak of Brucella melitensis infection by airborne transmission among laboratory workers

Rev. 1 Brucella melitensis vaccine. The stability of the degree of attenuation

Citations

Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB/c mice

The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams

Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis

Immune response and serum bactericidal activity against Brucella ovis elicited using a short immunization schedule with the polymeric antigen BLSOmp31 in rams

Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens

A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice

Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis

Virulence factors in brucellosis: implications for aetiopathogenesis and treatment

Human illness associated with use of veterinary vaccines

Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine

Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses

A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response

Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection

Protective properties of rifampin-resistant rough mutants of Brucella melitensis

What have we learned from brucellosis in the mouse model?

Incidence of human brucellosis in a rural area in Western Greece after the implementation of a vaccination programme against animal brucellosis.

Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Stability of poly(epsilon-caprolactone) microparticles containing Brucella ovis antigens as a vaccine delivery system against brucellosis

Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies.

Assessment of genetic stability of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable-number tandem repeat analysis

Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308

Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs

Veterinary pharmacovigilance. Part 4. Adverse reactions in humans to veterinary medicinal products

Progress in Brucella vaccine development

Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting

Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria

Optimization of the entrapment of bacterial cell envelope extracts into microparticles for vaccine delivery

Occupational exposure to Brucella spp.: A systematic review and meta-analysis

Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease

The CO2 -dependence of Brucella ovis and Brucella abortus biovars is caused by defective carbonic anhydrases

The BtaF Adhesin Is Necessary for Full Virulence During Respiratory Infection by Brucella suis and Is a Novel Immunogen for Nasal Vaccination Against Brucella Infection

Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Brucella abortus, B. melitensis and B. suis

Disruption of pyruvate phosphate dikinase in Brucella ovis PA CO2-dependent and independent strains generates attenuation in the mouse model.

Adhesins of Brucella : Their Roles in the Interaction with the Host

Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice.

Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines.

Accidental exposure to Brucella abortus vaccines and occupational brucellosis among veterinarians in Minas Gerais state, Brazil.

Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines.

Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.

Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis.

When the Going Gets Rough: The Significance of Brucella Lipopolysaccharide Phenotype in Host-Pathogen Interactions.

Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge

Related Concepts

Related Feeds

Brucellosis

Brucellosis (ASM)

Related Papers

Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams

A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats

Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies

The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice

A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice